PM
IOVA icon

Parametrica Management’s Iovance Biotherapeutics IOVA Stock Holding History

Parametrica Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$815K Hold
195,878
– – 0.64% 18
2026
Q1 		$688K Hold
195,878
– – 0.78% 17
2025
Q4 		$535K Hold
195,878
– – 0.82% 18
2025
Q3 		$425K Hold
195,878
– – 0.66% 21
2025
Q2 		$337K Hold
195,878
– – 0.63% 20
2025
Q1 		$652K Sell
195,878
-65,212
-25% -$336K 1.1% 17
2024
Q4 		$1.93M Hold
261,090
– – 2.55% 11
2024
Q3 		$2.45M Hold
261,090
– – 2.92% 10
2024
Q2 		$2.09M Buy
261,090
+129,500
+98% +$1.39M 2.77% 14
2024
Q1 		$1.95M Sell
131,590
-188,686
-59% -$2.2M 2.81% 12
2023
Q4 		$2.6M Buy
320,276
+224,876
+236% +$1.18M 4.27% 6
2023
Q3 		$434K Sell
95,400
-1,100
-1% -$7.18K 0.73% 27
2023
Q2 		$679K Buy
96,500
+47,800
+98% +$342K 1.31% 22
2023
Q1 		$298K Buy
48,700
+800
+2% +$5.52K 0.54% 21
2022
Q4 		$306K Sell
47,900
-46,750
-49% -$365K 0.63% 29
2022
Q3 		$907K Sell
94,650
-21,220
-18% -$245K 1.85% 13
2022
Q2 		$1.27M Sell
115,870
-18,809
-14% -$246K 1.38% 19
2022
Q1 		$2.24M Sell
134,679
-14,502
-10% -$224K 1.66% 12
2021
Q4 		$2.85M Buy
149,181
+2,819
+2% +$62.1K 2.83% 12
2021
Q3 		$3.61M Buy
146,362
+72,087
+97% +$1.7M 2.7% 11
2021
Q2 		$1.93M Buy
+74,275
New +$1.93M 1.43% 25
2020
Q3 		– Sell
-8,754
Closed -$240K – 120
2020
Q2 		$240K Buy
+8,754
New +$288K 0.26% 93

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Parametrica Management's IOVA Position: Q2 2026 in Review

Parametrica Management held its Iovance Biotherapeutics (IOVA) position steady in Q2 2026 at 195,878 shares worth $815K. The position accounts for 0.64% of the portfolio, ranked #18.

Parametrica Management first reported a position in IOVA in Q2 2020 and has held it in 22 quarters since. The position peaked at $3.61M in Q3 2021. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Parametrica Management held 195,878 shares of Iovance Biotherapeutics worth $815K as of Q2 2026.
  • Parametrica Management left its Iovance Biotherapeutics share count unchanged in Q2 2026.
  • Iovance Biotherapeutics made up 0.64% of Parametrica Management's portfolio in Q2 2026, its #18 holding.
  • Parametrica Management first reported a position in Iovance Biotherapeutics in Q2 2020 and has held it in 22 quarters since.
  • Parametrica Management's Iovance Biotherapeutics position peaked at $3.61M in Q3 2021.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Parametrica Management's 13F filing for Q2 2026, filed 12 Aug 2026.